Thr376
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Thr376  -  MOR-1 (mouse)

Site Information
NtREHPstANtVDRT   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 20727901

In vivo Characterization
Methods used to characterize site in vivo:
immunoassay ( 2 ) , mass spectrometry ( 5 ) , mutation of modification site ( 2 , 5 ) , phospho-antibody ( 2 , 3 ) , western blotting ( 2 , 3 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Putative in vivo kinases:
GRK2 (human) ( 2 ) , GRK3 (human) ( 2 )
Treatments:
Cmpd101 ( 2 ) , DAMGO ( 2 , 3 ) , morphine ( 2 , 5 ) , phorbol_ester ( 3 ) , siRNA ( 2 )

Downstream Regulation
Effects of modification on MOR-1:
molecular association, regulation ( 2 ) , receptor internalization, induced ( 5 )
Effects of modification on biological processes:
endocytosis, induced ( 5 )
Induce interaction with:
ARRB2 (human) ( 2 )

References 

1

Gillis A, et al. (2020) Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists. Sci Signal 13
32234959   Curated Info

2

Miess E, et al. (2018) Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid μ-opioid receptor desensitization. Sci Signal 11
30018083   Curated Info

3

Illing S, Mann A, Schulz S (2014) Heterologous regulation of agonist-independent μ-opioid receptor phosphorylation by protein kinase C. Br J Pharmacol 171, 1330-40
24308893   Curated Info

4

Just S, et al. (2013) Differentiation of opioid drug effects by hierarchical multi-site phosphorylation. Mol Pharmacol 83, 633-9
23239825   Curated Info

5

Lau EK, et al. (2011) Quantitative encoding of the effect of a partial agonist on individual opioid receptors by multisite phosphorylation and threshold detection. Sci Signal 4, ra52
21868358   Curated Info